Mostrar el registro sencillo del ítem

dc.contributor.authorCastro, Carmen
dc.contributor.authorGalán Sánchez, Fátima 
dc.contributor.authorLinares, Mª José
dc.contributor.authorTejero, Rocío
dc.contributor.authorRuiz, Maite
dc.contributor.authorSerrano, Mª Luisa
dc.contributor.authorRodríguez Iglesias, Manuel Antonio 
dc.contributor.authorMartín-Mazuelos, Estrella
dc.contributor.otherBiomedicina, Biotecnología y Salud Públicaes_ES
dc.date.accessioned2026-09-14T09:52:35Z
dc.date.available2026-09-14T09:52:35Z
dc.date.issued2019
dc.identifier.issn1460-2709
dc.identifier.issn1369-3786
dc.identifier.urihttp://hdl.handle.net/10498/40224
dc.description.abstractWe analyzed the species distribution and susceptibility patterns of 433 strains of Aspergillus spp. isolated from respiratory samples of 419 in-patients included in multicenter prospective study (FUNGAE-IFI) between July 2014 and October 2015. Identification was carried out by conventional methods at each participating center and by molecular sequencing of a portion of the β-tubulin gene at one of the centers. In vitro susceptibility was evaluated by broth microdilution methods and using the E-test (for cryptic species). Species identified included 249 A. fumigatus sensu stricto, 60 A. terreus sensu stricto, 47 A. flavus sensu stricto, 44 A. tubingensis, 18 A. niger sensu stricto , five A. nidulans sensu stricto, three A. tamarii, two A. calidoustus, two A. carneus, one A. acuelatus, one A. carbonarius, and one A. sydowii. Cryptic species were found in 12.5% of isolates (n = 54). The frequency of non-wild-type isolates for amphotericin B was 3.4% (n = 15) of the isolates tested and for azoles 3% (n = 10). None of the Aspergillus spp. were non-wild type to echinocandins. Of the 54 cryptic species only two strains were non-wild-type strains by microdilution method (3.7%) (two A. tubingensis, one to amphotericin B and another one to voriconazole) and by E-test method five strains of A. tubingensis showed high minimal inhibitory concentration (MIC) to amphotericin B (11.4%) and five to azoles (12.1%), one A. calidoustus strain showed high MICs for three azoles (50%), A. carneus to itraconazole (100%) and A. sydowii to amphotericin B and itraconazole (100%). These results provide relevant information on susceptibility patterns, frequency, and epidemiology of species involved in respiratory tract samples and of the incidence of recently described cryptic species.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherOxford University Presses_ES
dc.sourceMedical Mycology - 2019, Vol.57 n.4 pp. 412-420es_ES
dc.subjectAspergillus sppes_ES
dc.subjectCryptic specieses_ES
dc.subjectHospitalized patientses_ES
dc.subjectRespiratory tract sampleses_ES
dc.titleA prospective survey of Aspergillus spp. in respiratory tract samples: Species identification and susceptibility patternses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsclosed accesses_ES
dc.identifier.doi10.1093/mmy/myy080
dc.type.hasVersionNAes_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem